21 CFR 862.1040
§ 862.1040 Aldolase test system.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 862.1040, § 862.1040 Aldolase test system, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89041
- Permanent ID
ys:prov:89041@1- SHA-256
b3e0b6d1e997d0914c9b04575ead641a00f0e8ffa7f6a7aa75ec3cbd996a0764
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. An aldolase test system is a device intended to measure the activity of the enzyme aldolase in serum or plasma. Aldolase measurements are used in the diagnosis and treatment of the early stages of acute hepatitis and for certain muscle diseases such as progressive Duchenne-type muscular dystrophy.
(b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.